Adjunctive eslicarbazepine acetate in pediatric patients with focal epilepsy: a systematic review and meta-analysis
- Lattanzi, Simona
- Brigo, Francesco
- Grillo, Elisabetta
- Cagnetti, Claudia
- Verrotti, Alberto
- Zaccara, Gaetano
- Silvestrini, Mauro
Publication date
January 2018
DOI Publisher
Springer Science and Business Media LLCAbstract
In the treatment of pediatric epilepsy, there is a critical demand for effective and safe therapeutic options to address patients' unmet clinical needs. Eslicarbazepine acetate is a novel once-daily antiepileptic drug and a third-generation single enantiomer member of the dibenzazepine family
Extracted data
We use cookies to provide a better user experience.